Trial intelligence / Profile preview

IVORY study of oral versus intravenous sildenafil after pediatric cardiac surgery

2011-002707-16Phase 2Active

Sponsor
Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón
Start
Jan 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 2 trial of sildenafil in pulmonary hypertension (PH) (2 arms), sponsored by Fundación Investigación Biomédica Hospital General Universitario Gregorio Marañón. Primary endpoint: Systemic exposure. Started Jan 2014; status: active.

02

Drugs

sildenafil
03

Conditions

pulmonary hypertension (PH)

Beyond the preview

Go deeper on 2011-002707-16.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2011-002707-16.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call